Moreover, several preclinical studies have suggested the significance of PDE7 as a novel therapeutic target for neuropsychiatric diseases, including Parkinson’s disease [9], Alzheimer’s disease [10], and addiction [11]. Here, PDE7A is linked to Alzheimer disease.